Welcome
Ironwood Cancer & Research Centers strive to be comprehensive care facilities providing a full spectrum of services to patients with oncologic and hematologic diseases. Our state of the art facilities are the first of their kind in the East Valley, housing a full staff to provide leading edge, quality care in Medical Oncology along with Radiation Oncology and ancillary support services.
Latest Cancer News
Test Available for Pre-surgical Evaluation of Ovarian Mass
(03-11-2010)
For women who require surgery for an ovarian mass, the OVA1™ test may help identify the most appropriate type of surgeon. The test assesses the likelihood that cancer is present; when cancer is likely,... Continue Reading
Obesity Linked with Worse Colon Cancer Outcomes (03-10-2010)
Compared with healthy-weight patients, obese colon cancer patients have a higher risk of cancer recurrence and death. These results were published in Clinical Cancer Research. Obesity is increasingly... Continue Reading
Oncotype DX® Predicts Recurrence Risk in Node-negative and Node-positive Breast Cancer Treated with Tamoxifen or Arimidex (03-9-2010)
Among postmenopausal women with early, hormone receptor-positive breast cancer treated with either tamoxifen (Nolvadex®) or Arimidex® (anastrozole), the Oncotype DX test predicts the risk of distant... Continue Reading
For women who require surgery for an ovarian mass, the OVA1™ test may help identify the most appropriate type of surgeon. The test assesses the likelihood that cancer is present; when cancer is likely,... Continue Reading
Obesity Linked with Worse Colon Cancer Outcomes (03-10-2010)
Compared with healthy-weight patients, obese colon cancer patients have a higher risk of cancer recurrence and death. These results were published in Clinical Cancer Research. Obesity is increasingly... Continue Reading
Oncotype DX® Predicts Recurrence Risk in Node-negative and Node-positive Breast Cancer Treated with Tamoxifen or Arimidex (03-9-2010)
Among postmenopausal women with early, hormone receptor-positive breast cancer treated with either tamoxifen (Nolvadex®) or Arimidex® (anastrozole), the Oncotype DX test predicts the risk of distant... Continue Reading